ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Cantaloupe Inc

Cantaloupe Inc (CTLP)

7.655
-0.155
( -1.98% )
Updated: 14:59:12

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
7.655
Bid
7.65
Ask
7.66
Volume
102,361
7.62 Day's Range 7.82
5.745 52 Week Range 8.23
Market Cap
Previous Close
7.81
Open
7.81
Last Trade
100
@
7.655
Last Trade Time
15:00:31
Financial Volume
$ 789,751
VWAP
7.7154
Average Volume (3m)
295,847
Shares Outstanding
72,809,713
Dividend Yield
-
PE Ratio
121,600.00
Earnings Per Share (EPS)
-
Revenue
244M
Net Profit
10k

About Cantaloupe Inc

Cantaloupe Inc, formerly USA Technologies Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Connect, ePort ... Cantaloupe Inc, formerly USA Technologies Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Connect, ePort Cashless Hardware, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and Two-Tier Pricing Program. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. Show more

Sector
Business Services, Nec
Industry
Caculate,acct Mach,ex Comp
Headquarters
Malvern, Pennsylvania, USA
Founded
2001
Cantaloupe Inc is listed in the Business Services sector of the NASDAQ with ticker CTLP. The last closing price for Cantaloupe was $7.81. Over the last year, Cantaloupe shares have traded in a share price range of $ 5.745 to $ 8.23.

Cantaloupe currently has 72,809,713 shares outstanding. The market capitalization of Cantaloupe is $568.64 million. Cantaloupe has a price to earnings ratio (PE ratio) of 121600.00.

CTLP Latest News

Enlivex Receives Regulatory Authorization For The Initiation Of A Phase I Clinical Trial To Evaluate Allocetra In Patients With Psoriatic Arthritis

•   First study of AllocetraTM in psoriatic arthritis, a chronic inflammatory condition that causes joint pain, swelling and stiffness, affects as many as 30% of people with psoriasis1, and has...

Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis

  First patient dosed with AllocetraTM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of peopleThumb osteoarthritis currently has no...

Join Enlivex Therapeutics’ Chief Executive Officer for a Live Investor Webinar and Q&A Session on June 25

Ness-Ziona, Israel, June 20, 2024 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company” or “Enlivex”), a clinical-stage macrophage reprogramming immunotherapy company, is...

Enlivex Announces Positive Interim Data Readout from a Phase I/II Trial Evaluating Allocetra in End-Stage Knee Osteoarthritis

Key Highlights Enrolled patients with severe knee osteoarthritis who were indicated for knee-replacement surgery received a single local injection of AllocetraTM into the knee as a “last...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.6859.827833572456.977.856.91523149737.49125139CS
41.05515.98484848486.67.856.242546777.0167428CS
121.68528.22445561145.977.855.782958476.80709388CS
260.93513.91369047626.727.855.7453094356.5619323CS
520.2052.751677852357.458.235.7453048106.74962616CS
156-2.685-25.967117988410.3413.252.773130536.3731028CS
260-5.335-41.070053887612.9913.252.773176606.88757367CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TWOU2U Inc
$ 3.36
(168.80%)
126.42M
LIPOLipella Pharmaceuticals Inc
$ 0.858
(112.32%)
187.68M
YIBOPlanet Image International Ltd
$ 4.5562
(56.30%)
28.48M
NIPGNIP Group Inc
 13.9116
(54.23%)
6.2M
TIVCTivic Health Systems Inc
$ 0.664501
(47.01%)
88.4M
CGTXCognition Therapeutics Inc
$ 1.42
(-40.08%)
23.82M
CEROCERo Therapeutics Holdings Inc
$ 0.1799
(-29.73%)
7.39M
NXTTNext Technology Holding Inc
$ 1.1599
(-24.19%)
511.77k
VTVTvTv Therapeutics Inc
$ 16.22
(-23.49%)
128.59k
LUXHLuxUrban Hotels Inc
$ 0.147
(-23.04%)
5.89M
NVDANVIDIA Corporation
$ 111.652
(-1.25%)
194.4M
LIPOLipella Pharmaceuticals Inc
$ 0.858
(112.32%)
187.68M
SQQQProShares UltraPro Short QQQ
$ 9.06
(-0.44%)
134.07M
TWOU2U Inc
$ 3.36
(168.80%)
126.42M
NLSPNLS Pharmaceutics Ltd
$ 0.240001
(26.32%)
115.41M

CTLP Discussion

View Posts
tigerpac tigerpac 11 months ago
Out at 7.10….suspect I will have to do more of these short term trades as long as there is volatility.
👍️0
tigerpac tigerpac 11 months ago
Added more at 6.75 morning for a swing trade.
👍️0
tigerpac tigerpac 11 months ago
Add more under 7.5 this morning. Earnings out tomorrow after close. I expect 20%+ sales growth once again and earnings starting to follow suit. 32M acquisition from six months ago already paying dividends as cross selling is boosting business. Smaller players buying first and larger players in industry now coming aboard as they realize the change in the landscape.
👍️0
tigerpac tigerpac 1 year ago
Been staircase buying from 5 to 8 over the past six months to add to my original position from years ago when it was above 10 (USAT).

I think the company has finally turned the corner and expect great things from them over the next two years.
👍️0
tigerpac tigerpac 1 year ago
Stay FAR away from that ticket or at least only consider if item drops to 40.

No revenue, too much expenses , even if new company comes in, won’t help imo.
👍️0
Think1st Think1st 1 year ago
How are you?
Can you please look into inqd and pm me on your thoughts..than you
👍️0
tigerpac tigerpac 1 year ago
Finally these guys have figured out how to make money. Could be the start of a long ascent.
👍️0
LARRY260 LARRY260 3 years ago
These comments back up Sutton’s Buy rating and $15 price target, which implies an upside of 83% in the next 12 months. Sutton high on CTLP???
👍️0
velcro velcro 3 years ago
Officers buying more shares, so I bought a few more shares.
👍️0
tigerpac tigerpac 3 years ago
I think the only answer to your question is thru acquisition. They are counting on a return to pre-pandemic volume on their legacy business. Subscription fees will certainly be a plus going forward.

Where is the company going to come up with a product that produces more profit?
👍️0
LARRY260 LARRY260 3 years ago
Where is the company going to come up with a product that produces more profit?
👍️0
tigerpac tigerpac 3 years ago
Bought back into CTLP on heels of last earnings report. Although they missed revenue by a million and there was a loss of about $1.2 million, the company has been buying back shares with cash flow.

Also, technically a Golden Cross will happen shortly so looking for a bounce.
👍️0
LARRY260 LARRY260 3 years ago
Youtube video of USAT to CTLP future...
👍️0
LARRY260 LARRY260 3 years ago
Pushing the software more now? Looks like it may work for awhile?
👍️0
surfsup10 surfsup10 3 years ago
Maybe... but they should of left it alone. I was doing good trading it back n forth before the 'pandemic'. Since then.. its been kinda idle
👍️0
LARRY260 LARRY260 3 years ago
Trying to deflect away from being seen as a vending machine card reading business and pushing to be more a small business cashless system would be my guess. May work out and make a sale possible??
👍️0
surfsup10 surfsup10 3 years ago
Why are we in the fruit business now? Just saw the name change in my acct... lol
👍️0
LARRY260 LARRY260 3 years ago
Where do we go from here?
👍️0

Your Recent History

Delayed Upgrade Clock